On February 12, 2025, CME Group Inc (CME, Financial) released its 8-K filing reporting a remarkable financial performance for the fourth quarter and full year of 2024. The company achieved record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share, marking a significant milestone in its financial history.
Based in Chicago, CME Group Inc (CME, Financial) operates as a leading derivatives marketplace, offering a wide range of global benchmark products across various asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company has expanded its reach through strategic acquisitions and partnerships, including a 27% stake in S&P Dow Jones Indices.
For the fourth quarter of 2024, CME Group Inc (CME, Financial) reported revenue of $1.5 billion, slightly below the analyst estimate of $1.51878 billion. However, the company's diluted earnings per share (EPS) of $2.40 exceeded the estimated EPS of $2.38. On an adjusted basis, the EPS was $2.52, further surpassing expectations. The company's performance was driven by volume growth across all asset classes, setting new records in interest rates, agricultural, foreign exchange, and metals markets.
CME Group Inc (CME, Financial) reported a record annual revenue of $6.1 billion for 2024, a 10% increase from the previous year, slightly below the annual revenue estimate of $6.11489 billion. The company's net income for the year was $3.5 billion, with a diluted EPS of $9.67, slightly above the estimated annual EPS of $9.64. On an adjusted basis, the net income was $3.7 billion, and the diluted EPS was $10.26.
The company's clearing and transaction fees revenue for the fourth quarter totaled $1.2 billion, with a total average rate per contract of $0.701. Market data revenue reached $182 million. As of December 31, 2024, CME Group Inc (CME, Financial) held approximately $3.1 billion in cash and $3.4 billion in debt. The company declared dividends totaling $3.8 billion during 2024, including a significant annual variable dividend of $2.1 billion.
In 2024, CME Group had its best year ever, generating record annual average daily volume, revenue, adjusted operating income, adjusted net income, and adjusted earnings per share," said Terry Duffy, CME Group Chairman and Chief Executive Officer.
CME Group Inc (CME, Financial)'s strong financial performance underscores its ability to capitalize on market opportunities and manage risks effectively. The company's strategic focus on expanding its product offerings and enhancing its technological capabilities has positioned it well in the competitive capital markets industry. Despite economic and geopolitical uncertainties, CME Group Inc (CME) remains committed to serving its global clients and pursuing growth opportunities.
| Metric | Q4 2024 | Full Year 2024 |
|---|---|---|
| Revenue | $1.5 billion | $6.1 billion |
| Net Income | $875 million | $3.5 billion |
| Diluted EPS | $2.40 | $9.67 |
| Adjusted Net Income | $919 million | $3.7 billion |
| Adjusted Diluted EPS | $2.52 | $10.26 |
For more detailed insights and analysis, visit the full earnings report on the SEC website.
Explore the complete 8-K earnings release (here) from CME Group Inc for further details.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.